Ascendis Pharma A/S Reports First Quarter 2019 Financial Results

    NEXT STORY
    Merus Announces Financial Results for the First Quarter 2019 and Provides Business Update
    PREV STORY
    AB Science will hold a web conference on its outlook for 2019 on June 4 and 5, 2019 from 5.30 pm to 7pm CET
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    European Commission approves Venclyxto plus Gazyvaro for adults with previously untreated chronic lymphocytic leukaemia

    author_avatar
    NASDAQ Market News

    Cancer Genetics and Indian Cooperative Oncology Network (ICON) Collaborate to Reduce Alarmingly Increasing Cancer Mortality Rates

    Goal to bring CGI’s global expertise in clinical diagnostic assay development and as a ...

    author_avatar
    NASDAQ Market News

    Cellectar Biosciences Appoints Jarrod Longcor Chief Business Officer

    MADISON, Wis., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused ...

    author_avatar
    NASDAQ Market News